Please login to the form below

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

In this edition of ‘Perspective ’, the magazine of Blue Latitude Health, we examine the challenges and opportunities that have risen with the dawn of precision medicine.

The emergence of new targeted therapies and diagnostic tests have led to a more complex network of stakeholders than ever before. Now, industry is working with new players who each have a variety of needs, challenges and pain points.

We have spoken to these stakeholders to chart their journeys and the role they play in ensuring patients can access precision medicines. Read on to hear from patients, healthcare professionals, scientists, those transforming healthcare systems, diagnostic experts, and executives at innovative pharmaceutical companies.

Find out their personal stories and gain a behind-the-scenes look at the role they play in driving novel healthcare innovations. Once you have learned from these first-hand accounts, turn to our precision medicine ecosystem, which begins on p.50 . Here, we reveal key insights to help you meet the needs of seven core stakeholders involved in launching and delivering precision medicines.

Blue Latitude Health works with commercial and medical teams in top pharmaceutical companies and innovative biotechs. Our capabilities, from insight and strategy to creative execution, ensure we can solve our clients’ end-to-end commercial challenges. Our early stage service is specifically designed to help launch cutting-edge products, ensuring our clients make a real difference in patients’ lives.

Download the publication to learn:

* An overview of how precision medicine is impacting stakeholders across the precision medicine ecosystem

* Breast cancer patient Laura Holmes Haddad’s story of taking part in a novel PARP inhibitor clinical trial

* Laura oncologist gives his perspective of the PARP inhibitor clinical trial along with his advice for industry

* What it’s like to treating paediatric patients with CAR-T at Great Ormond Street Children’s hospital

* How Genomics England is rolling out precision medicine across the nation

* Nancy Brandt explains how a top biopharma company is transforming internally to ensure it sits at the forefront of innovation

* Insights from seven key stakeholders, from payers and regulators, to healthcare technology, diagnostic companies, pharmaceuticals, healthcare professionals and patients.

Download the full publication here

31st May 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
Great creative is effective creative. And effective creative is affective creative
Our creative approach at Fishawack Health is Affective Creativity. Creative crafted to make deep, motivating connections with our target audience. We tap into psychology and combine that with creative craft and expertise and to deliver powerful, engaging work on a conscious as well as a subconscious level.
Blue Latitude Health